SICILIANO, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 54.934
AS - Asia 23.486
EU - Europa 20.287
SA - Sud America 3.795
AF - Africa 1.224
OC - Oceania 98
Continente sconosciuto - Info sul continente non disponibili 14
Totale 103.838
Nazione #
US - Stati Uniti d'America 51.294
IT - Italia 8.228
SG - Singapore 7.490
CN - Cina 6.539
HK - Hong Kong 3.852
CA - Canada 3.296
BR - Brasile 3.159
SE - Svezia 2.513
DE - Germania 2.274
VN - Vietnam 1.962
BG - Bulgaria 1.468
GB - Regno Unito 1.105
TR - Turchia 1.014
FR - Francia 860
FI - Finlandia 852
RU - Federazione Russa 733
UA - Ucraina 625
IN - India 536
CI - Costa d'Avorio 505
KR - Corea 433
AT - Austria 393
JP - Giappone 363
CH - Svizzera 302
BD - Bangladesh 237
NL - Olanda 230
AR - Argentina 187
MX - Messico 176
IQ - Iraq 169
SN - Senegal 142
NG - Nigeria 130
ZA - Sudafrica 130
ES - Italia 129
PL - Polonia 124
BE - Belgio 106
ID - Indonesia 97
EC - Ecuador 93
PK - Pakistan 91
VE - Venezuela 88
SA - Arabia Saudita 84
IL - Israele 78
UZ - Uzbekistan 77
MA - Marocco 67
CO - Colombia 66
PH - Filippine 62
CL - Cile 51
AU - Australia 50
CZ - Repubblica Ceca 50
KE - Kenya 48
NZ - Nuova Zelanda 47
UY - Uruguay 47
EG - Egitto 44
IE - Irlanda 42
PY - Paraguay 41
PE - Perù 40
MY - Malesia 38
AE - Emirati Arabi Uniti 37
TN - Tunisia 34
IR - Iran 33
LT - Lituania 33
NP - Nepal 33
GR - Grecia 32
AZ - Azerbaigian 31
JO - Giordania 31
JM - Giamaica 27
BJ - Benin 26
HU - Ungheria 26
KZ - Kazakistan 25
OM - Oman 25
PA - Panama 24
RO - Romania 22
DZ - Algeria 21
CR - Costa Rica 20
DK - Danimarca 20
ET - Etiopia 20
DO - Repubblica Dominicana 19
TW - Taiwan 19
PT - Portogallo 18
BO - Bolivia 17
AL - Albania 16
LB - Libano 16
NI - Nicaragua 16
KG - Kirghizistan 15
HN - Honduras 14
TH - Thailandia 14
TT - Trinidad e Tobago 13
PS - Palestinian Territory 12
BH - Bahrain 11
GE - Georgia 11
LV - Lettonia 11
RS - Serbia 11
AO - Angola 10
GT - Guatemala 10
LY - Libia 10
AM - Armenia 9
BA - Bosnia-Erzegovina 9
BB - Barbados 8
EE - Estonia 8
SK - Slovacchia (Repubblica Slovacca) 8
EU - Europa 7
HR - Croazia 7
Totale 103.696
Città #
Woodbridge 5.591
Ashburn 5.047
Singapore 4.180
Houston 3.808
Hong Kong 3.784
Fairfield 3.780
Ann Arbor 3.390
Chandler 2.769
San Jose 2.732
Dallas 2.665
Santa Clara 2.525
Montreal 2.365
Seattle 1.775
Milan 1.607
Sofia 1.464
Shanghai 1.461
Beijing 1.356
Wilmington 1.334
Serra 1.314
Cambridge 1.273
New York 1.130
Jacksonville 798
Boardman 759
Ottawa 749
Los Angeles 693
Princeton 666
Izmir 626
Lawrence 594
Medford 553
Hefei 545
Lauterbourg 541
Abidjan 505
Ho Chi Minh City 481
Florence 448
Nanjing 432
Rome 428
Seoul 418
Vienna 335
Des Moines 332
Munich 331
Tokyo 329
Hanoi 316
Frankfurt am Main 305
Council Bluffs 301
Buffalo 273
Istanbul 269
Pisa 249
São Paulo 240
Redondo Beach 237
London 235
Bern 233
Dong Ket 226
San Diego 214
The Dalles 202
Columbus 200
Dearborn 188
Nanchang 187
Helsinki 181
Ogden 172
Turku 163
Jüchen 151
Bremen 143
Dakar 141
Redwood City 135
Orem 130
Lagos 126
Chicago 114
Rio de Janeiro 108
Kunming 106
Lancaster 102
Norwalk 100
Warsaw 100
Hebei 93
Shenyang 93
Changsha 92
Brussels 89
Düsseldorf 87
Belo Horizonte 84
Pune 79
Fuzhou 78
Da Nang 75
Naples 70
Tashkent 70
Brooklyn 68
Nuremberg 68
Phoenix 68
Tianjin 68
Baghdad 65
Livorno 65
San Francisco 65
Washington 64
Boulder 63
Guangzhou 63
Chennai 62
Toronto 62
Atlanta 61
Falls Church 60
Jiaxing 60
Johannesburg 60
Dhaka 55
Totale 73.747
Nome #
Stima della prevalenza della sclerosi laterale amiotrofica (SLA): elaborazione di un algoritmo dai dati sanitari routinari 2.576
A Clinical Tool for Prognosis and Speech Rehabilitation in Dysarthric Patients: The DESIRE Project 2.540
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 780
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 336
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 305
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease 297
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 277
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 273
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 272
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 272
Mozart’s music between predictability and surprise: results of an experimental research based on electroencephalography, entropy and Hurst exponent 251
Dream recall in patients with focal cerebral lesions. 250
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 246
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 244
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 244
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 240
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 239
Dysphagia in Amyotrophic Lateral Sclerosis: relationshisp between disease progression and fiberoptic endoscopic evaluation of swallowing. 239
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 239
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 239
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 233
Metabolic myopathies: functional evaluation by different exercise testing approaches 232
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 232
Antimyoclonic effect of levetiracetam in MERRF syndrome 231
The role of mitochondria in stem cell biology 231
Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children 229
Progressive sensorineural hearing loss in childhood 229
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 229
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects 227
Mitochondrial DNA-related disorders 225
Tetracycline treatment in patients with progressive external ophthalmoplegia. 225
Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? 224
Clinical Trials for Neuroprotection in ALS 224
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 223
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 223
Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance 222
Effects of anticholinergic agents on the excitability of the blink reflex in Meige syndrome. 222
Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia. 222
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 222
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 221
Thyroid function and oral TRH in amyotrophic lateral sclerosis 219
Detecting the vulnerable carotid plaque: the Carotid Artery Multimodality imaging Prognostic study design 218
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 218
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier 217
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 217
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 216
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. 215
Pain threshold and polysynaptic components of the blink reflex in Parkinson's disease. 215
Mitochondria, cognitive impairment, and Alzheimer's disease. 215
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 214
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 213
Oxidative stress modulation in neurodegenerative diseases 213
An atypical presentation of sporadic adult-onset centronuclear myopathy 213
A case of pelvic floor myoclonic jerk syndrome. 212
Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker 211
Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis? 211
High-resolution 7T MR imaging of the motor cortex in amyotrophic lateral sclerosis 211
Risk factors for CIDP: antecedent events, lifestyle and dietary habits. Data from the Italian CIDP database 211
Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals 209
Tarsal tunnel syndrome in seronegative spondyloarthropathy. 208
A novel mitochondrial tRNA(Ile) point mutation associated with chronic progressive external ophthalmoplegia and hyperCKemia. 208
Evidence of increased restless legs syndrome occurrence in chronic and highly disabling migraine 208
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis 208
Dream recall after sleep interruption in brain-injured patients. 207
Pes cavus and hereditary neuropathies: when a relationship should be suspected. 206
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 205
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 205
Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. 204
Mitochondrial non-syndromic sensorineural hearing loss: a clinical, audiological and pathological study from Italy, and revision of the literature 204
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 204
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? 204
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 204
Inflammatory myopathy in a patient with postural and kinetik tremor. 203
Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study 202
Reply to P.M. Foye ( Letter ) 202
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone. 202
The hOGG1 Ser326Cys polymorphism and Huntington's disease 201
Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 201
Physical exercise and oxidative stress in muscular dystrophies: is there a good balance? Exercise and oxidative stress in MDs 201
A mitochondrial tRNAPhe mutation causes MERRF syndrome [Sindrome MERRF associata a mutazione del tRNAPhe] 200
Psychiatric involvement in adult patients with mitochondrial disease. 200
Quantitative evaluations of systemic and neuromuscular modifications induced by specific training in sedentary subjects 199
A STANDARDIZED CLINICAL EVALUATION OF PATIENTS AFFECTED BY FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: THE FSHD CLINICAL SCORE 199
Mitochondria and neurodegeneration 198
Brain MRI in Monogenic Cerebral Small Vessel Diseases: A Practical Handbook 198
Astrocyte-neuron interactions in neurological disorders 197
The Role of Mitochondria in StemCell Biology 196
DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. 196
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone 196
A personal monitoring architecture to detect muscular fatigue in elderly. 196
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms? 196
.Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? 195
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 195
Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients 195
Congenital myopathies: Clinical phenotypes and new diagnostic tools 194
Novel spastin (SPG4) mutations in Italian patients with hereditary spastic paraplegia 193
Mitochondrial DNA single deletion in a patient with postural tremor. 193
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease 193
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 193
Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment. 193
Totale 27.155
Categoria #
all - tutte 286.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 286.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021752 0 0 0 0 0 0 0 0 0 0 0 752
2021/20226.582 134 390 182 434 1.180 842 183 403 308 218 486 1.822
2022/20239.154 953 1.138 600 813 1.025 1.068 117 672 1.661 106 808 193
2023/20249.950 844 781 880 512 1.050 1.252 401 265 178 2.577 445 765
2024/202521.234 195 818 324 1.261 1.987 2.074 1.942 1.247 2.133 2.651 2.305 4.297
2025/202623.956 1.661 2.965 2.993 2.072 2.354 2.127 3.577 1.190 1.231 2.050 1.395 341
Totale 104.899